Back to results
US 2010/0076195 A1Published application
Purification of montelukast
AssigneesTeva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.
InventorsGreta STERIMBAUM, Evgeny SHAPIRO, Kobi CHEN
Life of this patent
Estimating the term…
Abstract
The present invention provides methods of purifying montelukast, a new isolated impurity of montelukast, method for its isolation, and method of using montelukast impurity as a reference marker and a reference standard.
Claims3
1-3. (canceled)
An isolated impurity, [R-(E)]-1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-propenyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid (MLK-D) of the following structure:
5-16. (canceled)
Dependencies are inferred from the claim text.